EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Drug Discovery Today


 

Status
active
Indexing
BIOSIS Citation Index, Biochemistry and Biophysics , Citation Index, CAB International, Chemical Abstracts, Current Contents, Embase, International Pharmaceutical Abstracts, Life Science Collection, PubMed/Medline, Science Citation Index, Scopus, Web of Science
Subject

Source type
Journal
Publisher
ISBN ISSN
1359-6446
E ISSN
1878-5832
First volume
1
Last volume
25+
Publish city
Cambridge
Homepage
Description
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.

Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
Coverage includes:
Novel therapeutic strategies
High-throughput screening
Therapeutic targets
Combinatorial chemistry, parallel synthesis and library design
Drug delivery
ADME/Tox
• Advances in key compound classes and therapeutic areas
Genomics and proteomics
Automation and technology
Virtual chemistry
Informatics
Business strategy
Clinical trials
and other aspects of drug discovery.


Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )